First PPI Bellwether Trial Set to Begin on Sept. 21, 2020
First PPI Bellwether Trial Set to Begin on Sept. 21, 2020
Introduction
As per the U.S. District Court, District of New Jersey court order released on June 20, 2018, the first bellwether trial for the kidney injury lawsuits against Nexium and other PPI manufacturers will convene on September 21, 2020.
Over 4,500 lawsuits are federally-filed against PPI manufacturers over claims that the heartburn drugs Nexium, Prilosec, Prevacid, Protonix, and Dexilant cause kidney complications. Plaintiffs accuse the drug makers of failing to provide adequate warnings to doctors and patients about the potential risks of the drugs. Lawsuits claim adverse events of renal malfunctions including Acute interstitial nephritis, Acute kidney injury, Chronic kidney disease, and Kidney failure. PPI lawsuits were centralized as part of the multidistrict litigation (MDL No. 2789; In Re: Proton-Pump Inhibitor Products Liability Litigation [No. II]) overlooked by Judge Claire C. Cecchi in the District of New Jersey.
Comments
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Categories: Opioids
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
Categories: Philips CPAP/BiPAP/ASV Sleep Apnea Machines
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Categories: Opioids
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…